Evidence map›Paper›PMID 35558860›Full record

ArticleRSC advances2022

Potential antimicrobial, antidiabetic, catalytic, antioxidant and ROS/RNS inhibitory activities of

Junaid Iqbal, Anisa Andleeb, Hajra Ashraf, Bisma Meer, Azra Mehmood, Hasnain Jan, Gouhar Zaman, Muhammad Nadeem, Samantha Drouet, Hina Fazal and 3 more

Abstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antibacterial Properties of Copper Oxide Nanoparticles (Review).International journal of molecular sciences · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Junaid IqbalDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan juniqbal34@gmail.com anisaandleeb@bs.qau.edu.pk hajraashraf67@gmail.com bismameer786@gmail.com gzaman@bs.qau.edu.pk bhabbasi@qau.edu.pk.ORCID https://orcid.org/0000-0002-4750-3751
Anisa AndleebDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan juniqbal34@gmail.com anisaandleeb@bs.qau.edu.pk hajraashraf67@gmail.com bismameer786@gmail.com gzaman@bs.qau.edu.pk bhabbasi@qau.edu.pk.
Hajra AshrafDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan juniqbal34@gmail.com anisaandleeb@bs.qau.edu.pk hajraashraf67@gmail.com bismameer786@gmail.com gzaman@bs.qau.edu.pk bhabbasi@qau.edu.pk.
Bisma MeerDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan juniqbal34@gmail.com anisaandleeb@bs.qau.edu.pk hajraashraf67@gmail.com bismameer786@gmail.com gzaman@bs.qau.edu.pk bhabbasi@qau.edu.pk.
Azra MehmoodStem Cell & Regenerative Medicine Lab, National Centre of Excellence in Molecular Biology, University of Punjab 87-West Canal Bank Road Lahore 53700 Pakistan azramehmood@cemb.edu.pk.
Hasnain JanInstitute of Biochemical Sciences, National Taiwan University Taipei City 10617 Taiwan rhasnain849@gmail.com.
Gouhar ZamanDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan juniqbal34@gmail.com anisaandleeb@bs.qau.edu.pk hajraashraf67@gmail.com bismameer786@gmail.com gzaman@bs.qau.edu.pk bhabbasi@qau.edu.pk.
Muhammad NadeemInstitute of Integrative Biosciences, CECOS University Peshawar 25100 Pakistan m.nadeem@cecos.edu.pk.
Samantha DrouetLaboratoire de Biologie des Ligneux et des Grandes Cultures (LBLGC), INRAE USC1328, Université d'Orléans 45067 Orléans Cedex 2 France samantha.drouet@univ-orleans.fr hano@univ-orleans.fr.
Hina FazalPakistan Council of Scientific and Industrial Research (PCSIR) Laboratories Complex Peshawar 25120 Pakistan hina_fazalso@yahoo.com.
Nathalie Giglioli-Guivarc'hEA2106 Biomolécules et Biotechnologies Végétales, Université Francois-Rabelais de Tours Tours France nathalie.guivarch@univ-tours.fr.
Christophe HanoLaboratoire de Biologie des Ligneux et des Grandes Cultures (LBLGC), INRAE USC1328, Université d'Orléans 45067 Orléans Cedex 2 France samantha.drouet@univ-orleans.fr hano@univ-orleans.fr.ORCID https://orcid.org/0000-0001-9938-0151
Bilal Haider AbbasiDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan juniqbal34@gmail.com anisaandleeb@bs.qau.edu.pk hajraashraf67@gmail.com bismameer786@gmail.com gzaman@bs.qau.edu.pk bhabbasi@qau.edu.pk.ORCID https://orcid.org/0000-0002-6529-2134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Use of medicinal plants for the biosynthesis of nanoparticles offers several advantages over other synthesis approaches. Plants contain a variety of bioactive compounds that can participate in reduction and capping of nanoparticles. Plant mediated synthesis has the leverage of cost effectiveness, eco-friendly approach and sustained availability. In the current study

Identifiers

PMID35558860
PMCPMC9094097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.